Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Wigs significantly improve the well-being of people with severe hair loss.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.